B7-33 differs from full-length relaxin in being a single-chain peptide rather than a two-chain hormone, which makes it a simpler tool for studying RXFP1 activation in vitro. This guide compares the two.
Structural difference
Full-length relaxin is a two-chain, disulfide-linked peptide; B7-33 is a single chain derived from relaxin’s B-chain.
Why it matters in research
A single-chain peptide is simpler to synthesize and characterize, which is useful when studying RXFP1 signaling without the complexity of the two-chain structure.
Comparison table
| Property | Full-length relaxin | B7-33 |
|---|---|---|
| Chains | Two (A + B) | One |
| Receptor | RXFP1 | RXFP1 |
| Research use | Native reference | Simplified single-chain tool |
Source B7-33 with a batch COA for reproducible comparisons.
Related research guides
- B7-33: relaxin-receptor (RXFP1) research profile
- B7-33 structure & the relaxin family
- RXFP1 signaling in vitro
- Sourcing B7-33 (COA, purity)
Research-use note
All materials discussed are supplied for in vitro laboratory research use only, and are not for human or animal use.













